219 related articles for article (PubMed ID: 21350084)
21. Down-regulation of adipose 11beta-hydroxysteroid dehydrogenase type 1 by high-fat feeding in mice: a potential adaptive mechanism counteracting metabolic disease.
Morton NM; Ramage L; Seckl JR
Endocrinology; 2004 Jun; 145(6):2707-12. PubMed ID: 15044372
[TBL] [Abstract][Full Text] [Related]
22. Deconstructing the roles of glucocorticoids in adipose tissue biology and the development of central obesity.
Lee MJ; Pramyothin P; Karastergiou K; Fried SK
Biochim Biophys Acta; 2014 Mar; 1842(3):473-81. PubMed ID: 23735216
[TBL] [Abstract][Full Text] [Related]
23. Characterisation of 11beta-hydroxysteroid dehydrogenase 1 in human orbital adipose tissue: a comparison with subcutaneous and omental fat.
Bujalska IJ; Durrani OM; Abbott J; Onyimba CU; Khosla P; Moosavi AH; Reuser TT; Stewart PM; Tomlinson JW; Walker EA; Rauz S
J Endocrinol; 2007 Feb; 192(2):279-88. PubMed ID: 17283228
[TBL] [Abstract][Full Text] [Related]
24. 11β-Hydroxysteroid dehydrogenase type 1 (11β-HSD1) inhibitors still improve metabolic phenotype in male 11β-HSD1 knockout mice suggesting off-target mechanisms.
Harno E; Cottrell EC; Yu A; DeSchoolmeester J; Gutierrez PM; Denn M; Swales JG; Goldberg FW; Bohlooly-Y M; Andersén H; Wild MJ; Turnbull AV; Leighton B; White A
Endocrinology; 2013 Dec; 154(12):4580-93. PubMed ID: 24169553
[TBL] [Abstract][Full Text] [Related]
25. Increased glycogen synthase kinase-3β and hexose-6-phosphate dehydrogenase expression in adipose tissue may contribute to glucocorticoid-induced mouse visceral adiposity.
Yan C; Yang H; Wang Y; Dong Y; Yu F; Wu Y; Wang W; Adaku U; Lutfy K; Friedman TC; Tian S; Liu Y
Int J Obes (Lond); 2016 Aug; 40(8):1233-41. PubMed ID: 27102048
[TBL] [Abstract][Full Text] [Related]
26. 11β-Hydroxysteroid Dehydrogenase Type 1(11β-HSD1) mediates insulin resistance through JNK activation in adipocytes.
Peng K; Pan Y; Li J; Khan Z; Fan M; Yin H; Tong C; Zhao Y; Liang G; Zheng C
Sci Rep; 2016 Nov; 6():37160. PubMed ID: 27841334
[TBL] [Abstract][Full Text] [Related]
27. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
[TBL] [Abstract][Full Text] [Related]
28. 11Beta-HSD type 1 expression in human adipose tissue: impact of gender, obesity, and fat localization.
Paulsen SK; Pedersen SB; Fisker S; Richelsen B
Obesity (Silver Spring); 2007 Aug; 15(8):1954-60. PubMed ID: 17712112
[TBL] [Abstract][Full Text] [Related]
29. Benzofuran derivatives inhibit 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissue.
Kiyonaga D; Tagawa N; Yamaguchi Y; Wakabayashi M; Kogure T; Ueda M; Miyata O; Kobayashi Y
Biol Pharm Bull; 2012; 35(8):1275-80. PubMed ID: 22863925
[TBL] [Abstract][Full Text] [Related]
30. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
Tagawa N; Kubota S; Kato I; Kobayashi Y
J Endocrinol; 2013 Sep; 218(3):311-20. PubMed ID: 23814014
[TBL] [Abstract][Full Text] [Related]
31. Adipose tissue-targeted 11β-hydroxysteroid dehydrogenase type 1 inhibitor protects against diet-induced obesity.
Liu J; Wang L; Zhang A; Di W; Zhang X; Wu L; Yu J; Zha J; Lv S; Cheng P; Hu M; Li Y; Qi H; Ding G; Zhong Y
Endocr J; 2011; 58(3):199-209. PubMed ID: 21325744
[TBL] [Abstract][Full Text] [Related]
32. Ceramide and adenosine 5'-monophosphate-activated protein kinase are two novel regulators of 11beta-hydroxysteroid dehydrogenase type 1 expression and activity in cultured preadipocytes.
Arai N; Masuzaki H; Tanaka T; Ishii T; Yasue S; Kobayashi N; Tomita T; Noguchi M; Kusakabe T; Fujikura J; Ebihara K; Hirata M; Hosoda K; Hayashi T; Sawai H; Minokoshi Y; Nakao K
Endocrinology; 2007 Nov; 148(11):5268-77. PubMed ID: 17702848
[TBL] [Abstract][Full Text] [Related]
33. Emodin, an 11β-hydroxysteroid dehydrogenase type 1 inhibitor, regulates adipocyte function in vitro and exerts anti-diabetic effect in ob/ob mice.
Wang YJ; Huang SL; Feng Y; Ning MM; Leng Y
Acta Pharmacol Sin; 2012 Sep; 33(9):1195-203. PubMed ID: 22922341
[TBL] [Abstract][Full Text] [Related]
34. 11β-HSD1 contributes to age-related metabolic decline in male mice.
Morgan SA; Gathercole LL; Hassan-Smith ZK; Tomlinson J; Stewart PM; Lavery GG
J Endocrinol; 2022 Dec; 255(3):117-129. PubMed ID: 36205523
[TBL] [Abstract][Full Text] [Related]
35. Eicosapentaenoic acid reduces adipocyte hypertrophy and inflammation in diet-induced obese mice in an adiposity-independent manner.
LeMieux MJ; Kalupahana NS; Scoggin S; Moustaid-Moussa N
J Nutr; 2015 Mar; 145(3):411-7. PubMed ID: 25733455
[TBL] [Abstract][Full Text] [Related]
36. Antisense reduction of 11β-hydroxysteroid dehydrogenase type 1 enhances energy expenditure and insulin sensitivity independent of food intake in C57BL/6J mice on a Western-type diet.
Li G; Hernandez-Ono A; Crooke RM; Graham MJ; Ginsberg HN
Metabolism; 2012 Jun; 61(6):823-35. PubMed ID: 22209663
[TBL] [Abstract][Full Text] [Related]
37. Depot-specific modulation of rat intraabdominal adipose tissue lipid metabolism by pharmacological inhibition of 11beta-hydroxysteroid dehydrogenase type 1.
Berthiaume M; Laplante M; Festuccia W; Gélinas Y; Poulin S; Lalonde J; Joanisse DR; Thieringer R; Deshaies Y
Endocrinology; 2007 May; 148(5):2391-7. PubMed ID: 17272400
[TBL] [Abstract][Full Text] [Related]
38. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
Park JS; Rhee SD; Jung WH; Kang NS; Kim HY; Kang SK; Ahn JH; Kim KY
Eur J Pharmacol; 2012 Sep; 691(1-3):19-27. PubMed ID: 22760069
[TBL] [Abstract][Full Text] [Related]
39. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
[TBL] [Abstract][Full Text] [Related]
40. Overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in hepatic and visceral adipose tissue is associated with metabolic disorders in morbidly obese patients.
Baudrand R; Carvajal CA; Riquelme A; Morales M; Solis N; Pizarro M; Escalona A; Boza C; Pérez G; Domínguez A; Arrese M; Fardella CE
Obes Surg; 2010 Jan; 20(1):77-83. PubMed ID: 19690925
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
